Introduction and objective:

Meniere's disease (MD) is a chronic auditory pathology characterized by the presence of hearing loss, episodic dizziness and tinnitus. The objective of this studie is to value the hearing improvement and the reduction of vertiginous crises in patients with Meniere's disease after the administration of intratympanic corticosteroids (ITS).

Method:

Retrospective cohort study of a sample of 55 patients diagnosed with definitive Meniere's disease and treated with intratympanic corticosteroids.

Results:

Of the 39 patients who were treated with ITS for vertigo attacks, one month into the treatment, 27 had no attacks, 11 experienced a few (<5) and only 1 had several attacks (5-10). Six months after the first injection, 19 had no seizures, 13 reported a few, 5 had several, and 2 manifested numerous attacks (> 10). There were 16 patients treated with ITS for hearing loss and they reflected a mean hearing loss of 46.61 dB prior to the treatment. One month after the injection, the mean loss was 42.77 dB (1.84) and at six months it was 41.66 dB (2.95).

Discussion:

The audiometric benefit obtained is ≈3 dB und a clear decrease in the number of vertiginous crises after ITS, other authors in their studies have obtained results similar to ours.

Conclusions:

Our results show that intratympanic corticosteroids is an effective therapy for the control of vertiginous crises and hearing loss.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )